Transformative Fridays has completely transformed my life
| Take home message A recent announcement from Novo Nordisk, the pharmaceutical company that manufactures Wegovy (semaglutide 2.4mg), declared that preliminary results from their latest trial had shown a 20% reduction in the number of major cardiovascular events (MACE), like a heart attack or stroke, compared to placebo
Below 60 mg/dL is symptomatic hypoglycemia requiring immediate carbohydrate correction and medication review
For a detailed General Retatrutide Dosing Guide for Researchers Retatrutide Dosing: A Research Protocol Reference This guide compiles dosing information, reconstitution procedures, and storage guidelines for retatrutide based on published clinical trial literature and standard peptide handling protocols
AFib episodes last minutes to hours, not seconds
In this highlight of the b-complex shot, well cover the ins and outs as well as advantages and disadvantages, so you can make the most informed decision about whether this treatment is right for your needs
